GlobalData on MSN
FDA grants breakthrough designation to PathAI for pathology solution
The latest milestone follows PathAI’s 510(k) clearance for AISight Dx, the first FDA-approved digital pathology system.
- Results showed 100% sensitivity and reduced time to diagnosis by an estimated 65.5%, with potential to improve pathologists’ workflow in a real-world environment -Brazil-based Grupo Oncoclinicas is ...
PathAI, Inc., a global leader in artificial intelligence (AI)-powered pathology solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation ...
LigoLab, a leading provider of enterprise laboratory information system (LIS) software and fully integrated laboratory revenue cycle management (lab RCM) solutions, and PathPresenter, a global leader ...
NIJMEGEN, Netherlands--(BUSINESS WIRE)--Aiosyn, a software company that develops AI-powered pathology software, has launched its first product that assists digital pathology labs across research, ...
Key pathology workflow instruments including a next-generation tissue processor, precision microtome, and an ergonomically designed embedding center will debut at the 2025 National Society of ...
Voicebrook integration into Lumea’s pathology software enables practical, voice-enabled workflows across the modern pathology lab, from grossing to diagnosis. LEHI ...
PathPresenter, a pioneer in the development of digital pathology software, and 4D Path Inc., developer of a pan-cancer diagnostic and precision oncology platform enabling AI-based biomarker typing and ...
PARIS, July 7, 2021 /PRNewswire/ -- TRIBVN Healthcare today announced a new partnership with Lyon-based CYPATH. This collaboration will allow the group's 60 pathologists to move to a digital workflow ...
Cloud offering will help improve workflow integration, access, and reliability, delivering greater productivity and collaboration Collaboration combines best of clinical workflow leadership with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results